BIOMAT Database Logo BIOMAT Database Logo

Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. 2013

Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
Tianjin University of Traditional Chinese Medicine, 312 Anshanxi Road, Nankai District, Tianjin 300193, China.

Background. Several types of drugs have been recommended for the secondary prevention of myocardial infarction (MI). However, these conventional strategies have several limitations, such as low adherence, high cost, and side effects during long time use. Novel approaches to this problem are still needed. This trial aimed to test the effectiveness and safety of Qi-Shen-Yi-Qi Dripping Pills (QSYQ), a multi-ingredient Chinese patent medicine, for the secondary prevention of MI. Methods and Findings. A total of 3505 eligible patients were randomly assigned to QSYQ group (1746 patients) or aspirin group (1759). Patients took their treatments for 12 months. The final follow-up visit took place 6 months after the end of the trial drugs. The 12-month and 18-month estimated incidences of the primary outcome were 2.98% and 3.67%, respectively, in the QSYQ group. The figures were 2.96% and 3.81% in the aspirin group. No significant difference was identified between the groups. Conclusions. This trial did not show significant difference of primary and secondary outcomes between aspirin and QSYQ in patients who have had an MI. Though inconclusive, the result suggests that QSYQ has similar effects to aspirin in the secondary prevention of MI.

UI MeSH Term Description Entries

Related Publications

Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
QI-SHEN-YI-QI accelerates angiogenesis after myocardial infarction in rats.
August 2010, International journal of cardiology,
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
Qi-Shen-Yi-Qi Dripping Pills Promote Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells by Regulating MicroRNA-223-3p Expression.
January 2016, Evidence-based complementary and alternative medicine : eCAM,
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients.
May 2009, BMC cardiovascular disorders,
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
[Treatment of orthostatic dysregulation by the principle of bu-shen yi-qi].
May 1990, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine,
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
[Clinical effect of "Yi Qi Huo Xue" medicinal herbs in acute myocardial infarction: a randomized controlled study].
May 1983, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine,
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
[Protective effect of qi dong yi xin on acute myocardial infarction in dogs].
May 2003, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
Secondary prevention following myocardial infarction: a clinical update.
March 2018, The British journal of general practice : the journal of the Royal College of General Practitioners,
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.
September 2003, Lancet (London, England),
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial.
May 2022, Heart (British Cardiac Society),
Hongcai Shang, and Junhua Zhang, and Chen Yao, and Baoyan Liu, and Xiumei Gao, and Ming Ren, and Hongbao Cao, and Guohua Dai, and Weiliang Weng, and Sainan Zhu, and Hui Wang, and Hongjuan Xu, and Boli Zhang
[Preliminary experimental and clinical study of the treatment of chronic renal insufficiency by granule of yi-qi bu-shen].
June 1992, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine,
Copied contents to your clipboard!